The exciting part for me was that the 30 microgram dosed cohort was the most recent one. So they are now pretty sure that 3 & 10 micrograms aren’t sufficient. 30 works in at least younger patients.
Now they’re going to 75 micrograms. Maybe we’ll see even better response?
I think it was said they’d be dosed by the end of May? Can’t wait for the readouts from that!
Ann: Presentation of RP11 Clinical Trial Data at ARVO Conference, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 58344 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |